Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants.

Vista sencilla de ítem
dc.contributorEMANUELLE BALDO GASPAR, CPPSUL; LENITA RAMIRES DOS SANTOS, CNPGC; FLABIO RIBEIRO ARAUJO, CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; N. LINCOPAN, USP; HUMBERTO DE MELLO BRANDAO, CNPGL; GRACIA MARIA SOARES ROSINHA, CNPGC.
dc.creatorGASPAR, E. B.
dc.creatorSANTOS, L. R. dos
dc.creatorARAUJO, F. R.
dc.creatorGULIAS-GOMES, C. C.
dc.creatorLINCOPAN, N.
dc.creatorBRANDAO, H. de M.
dc.creatorROSINHA, G. M. S.
dc.date2025-06-25T15:47:47Z
dc.date2025-06-25T15:47:47Z
dc.date2013-02-07
dc.date2012
dc.date.accessioned2026-07-07T04:00:06Z
dc.descriptionThis project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering.
dc.formatp. 153.
dc.identifierIn: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012.
dc.identifierhttp://www.alice.cnptia.embrapa.br/alice/handle/doc/948750
dc.identifier.urihttp://hdl.handle.net/123456789/450190
dc.languageeng
dc.rightsopenAccess
dc.subjectAnaplasmose
dc.subjectBabesiose
dc.subjectVacina
dc.titleDevelopment of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants.
dc.typeResumo em anais e proceedings

Archivos

Colecciones

Embrapa Vacas Lecheras (CNPGL)